Hepatobiliary Medicine

Investigation is not a formality — it is the difference between a diagnosis you live with and one you can change.

Paths to an appointment

LiverGallbladderBile ducts
Schematic drawing, seen from the front. The bile ducts collect bile in the liver and carry it to the duodenum; the gallbladder stores it in the meantime.

The liver is one of the body’s most complex organs: it regulates metabolism, filters toxins, and produces bile. Elevated liver enzymes in laboratory findings are a common reason patients are referred to me, and in many cases there is more behind them than the initial assessment suggests.

Fatty liver is a common finding and is often instinctively associated with alcohol or excess weight, a simplification that does not always do patients justice. Alcohol belongs on the table as a matter of fact, without reproach: it is one possible factor among several, often not the only one, and how much it contributes in an individual case can be assessed — that is a medical question, not a moral one. Metabolic dysfunction-associated steatotic liver disease (MASLD) is becoming increasingly prevalent in the context of Western dietary patterns and sedentary lifestyles. Yet it is not the only explanation for chronically elevated liver enzymes: viral hepatitides, autoimmune liver conditions, gluten intolerance (coeliac disease), iron overload (haemochromatosis), and other conditions can underlie them, and are specifically treatable.

Fatty liver (MASLD)

Metabolic dysfunction-associated steatotic liver disease (MASLD) is closely tied to metabolism and body weight, and it is often discovered incidentally. What matters is not the fat deposition alone, but whether inflammation (steatohepatitis, MASH) or scarring of the tissue (fibrosis) has already developed: that is what determines the long-term risk, up to and including cirrhosis. Today this can largely be assessed without invasive procedures, using a measurement of liver stiffness (elastography) and simple laboratory values. The good news: in its early stages, fatty liver is reversible. The most effective lever is treating the underlying metabolic factors and weight; how I approach this is described in my Metabolic Medicine focus area. Liver-specific medications are beginning to emerge, and their availability in Austria is still evolving.

Elevated liver enzymes

Elevated liver enzymes are often noticed in passing, at a routine check-up or before an operation, and many of those affected feel entirely well. That is typical, because liver diseases cause no symptoms for a long time. Not every elevation means liver disease: an infection or intense exercise can raise the values temporarily, and medications and dietary supplements are possible causes as well. If the elevation is confirmed on a repeat test, or if it is marked, the cause should be investigated. The pattern already gives a first indication: some values (AST and ALT, listed as GOT and GPT on many Austrian laboratory reports) point more towards a disorder of the liver cells, others (gamma-GT, alkaline phosphatase) more towards the bile ducts. For me, the work-up includes a detailed consultation, an ultrasound examination, targeted blood tests and, where necessary, a measurement of liver stiffness (elastography). In most cases the cause can be clarified in this way, without a tissue sample (biopsy). What matters to me is that two questions are answered in the end: where the elevated values come from and what they mean for the future.

Bile ducts and gallstones

Alongside the liver cells themselves, the biliary tract matters: it carries breakdown products into the intestine. Obstructions or inflammation of the biliary tract have their own diagnostic and therapeutic spectrum. Most often it is gallstones that cause cramping pain (colic), jaundice, or inflammation, at times of the pancreas as well. Stones in the bile duct can usually be removed during an endoscopy (ERCP); the gallbladder itself is generally removed by surgery. In addition there are autoimmune biliary conditions such as primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), and IgG4-related sclerosing cholangitis (IgG4-SC). IgG4-related sclerosing cholangitis is the biliary manifestation of IgG4-related disease; it frequently occurs together with autoimmune pancreatitis and is one of the focuses of my work in the pancreatic outpatient clinic.

My commitment is thorough investigation of causes, early recognition of risk, and integrative care that brings together lifestyle management, pharmacological therapy, and specific treatment options in a meaningful way.

What I offer

Investigation and treatment of hepatic steatosis

Thorough investigation of causes in fatty liver (e.g. metabolic, alcoholic, drug-induced)

Investigating chronically elevated liver enzymes

Beyond fatty liver: e.g. viral, autoimmune, and toxic causes

Integrative care for metabolic liver disease (MASLD)

  • lifestyle guidance (nutrition, movement, psychological wellbeing)
  • pharmacological support for weight reduction and metabolic optimisation
  • assessment of scarring risk (fibrosis) with non-invasive methods such as elastography and laboratory values
  • MASLD-specific pharmacological therapies, where available

Treatment of liver-specific conditions

Including viral hepatitis (hepatitis B and C), autoimmune hepatitis, and haemochromatosis

Biliary tract conditions

Investigation and treatment of biliary obstruction and inflammation, including primary biliary cholangitis (PBC), IgG4-related sclerosing cholangitis (IgG4-SC), and primary sclerosing cholangitis (PSC); endoscopic therapy (ERCP) at the centre in St. Pölten

Review of indeterminate imaging findings

Shared understanding of incidental findings from ultrasound, CT, or MRI